© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Picamilon Sodium first turned up in scientific circles during the Soviet era, where researchers looked for ways to support mental health and performance in both everyday life and high-stress settings. The backdrop was the drive to find substances that go beyond simply improving memory, reaching into lowering anxiety and balancing moods. Chemists in Russia blended niacin (vitamin B3) with gamma-aminobutyric acid (GABA), hoping this compound would carry GABA across the brain's natural barriers. By the mid-1980s, Picamilon took on a role in Soviet medicine, especially in neurology and psychiatry clinics. The original goal: deliver meaningful brain support, not just short-term stimulation. Years later, Western countries started to look at it, though regulatory acceptance turned into a much bigger hurdle than the invention itself.
Picamilon Sodium lands in the market as a white or off-white crystalline powder, mixing the calming qualities of GABA with the blood-flow-enhancing properties of niacin. By connecting these two molecules, developers created a way to help GABA slip directly into the brain, passing the blood-brain barrier more effectively than supplementing either ingredient alone. Picamilon powders appear in dietary supplements or research labs, sometimes pressed into capsules or tablets. While some countries ban retail sales, others categorize it as a “nootropic”—a substance intended to sharpen cognitive function or support mental clarity during periods of pressure. Use among students, shift workers, and anyone keen on sustained mental activity demonstrates the broad demand for products like this, no matter how regulatory lines shift.
Picamilon Sodium’s appearance hints at its straightforward chemistry. Pure samples look like a white or nearly white crystalline powder with moderate water solubility. Its chemical formula, C10H11N2NaO3, reveals the fusion of niacin’s aromatic ring with GABA’s amine backbone, stabilized by a sodium salt. The compound dissolves best in water and fares poorly in nonpolar solvents. From a hands-on point of view, storage demands a dry, cool place away from direct sunlight or moisture, since the sodium salt form pulls in water from the air. It resists oxidation fairly well, which helps with shelf life and consistency from batch to batch. Lab techs who prepare solutions work with clear guidelines to keep concentrations stable, since even small impurities can throw off results.
Reliable labeling means detailing both the active ingredient and its significant excipients. Many products in retail or research supply stores state ‘Picamilon Sodium’ at concentrations like 98% or higher, usually pointing out molecular weight and purity percentages. Typical labels note the batch number, production date, and recommended storage conditions—for good reason, since even a trace of moisture changes the product’s punch and safety. Those who run testing routines look for impurities such as heavy metals or organic residues, pushing for thresholds well below regional safety limits. Regulatory pressure varies; pharmaceuticals call for tight documentation and background checks on raw materials, while supplement-grade batches face looser standards in some markets. The patchwork labeling landscape can leave users confused, so detailed certificates of analysis reassure buyers about what they’re receiving.
Creating Picamilon Sodium usually starts by condensing niacin (nicotinic acid) with GABA using a carbodiimide or other activating agent. Small-scale syntheses in academic labs sometimes substitute different dehydrating agents, but commercial manufacturers favor methods that deliver high yields and limit unwanted side products. After the GABA and niacin react, the compound is purified and treated with sodium hydroxide, turning it into the stable, water-soluble sodium salt. What matters in preparation: a gentle hand with pH adjustments and fine timing at each stage. Strictly controlling reaction temperature and pressure makes the difference between a clean product and batches loaded with contaminants. The purification stages often call on crystallization and multi-stage filtration to pull away excess reagents, coloring agents, and by-products that shouldn’t head into a finished product. Piece by piece, making high-quality Picamilon relies on both old-fashioned chemical insight and the quiet grind of modern monitoring instruments.
The core reaction in Picamilon formation ties GABA’s amino group to niacin’s carboxyl group, forming an amide bond. Chemists can tweak either end of this structure to generate derivatives—sometimes by altering the alkyl chain on GABA, sometimes by replacing the ring’s functional groups. Each adjustment shifts how the body handles the compound: larger rings can slow breakdown, side chains can boost or reduce solubility, and different salts (like potassium or calcium) tune stability or absorption. For example, swapping the sodium ion for another cation has drawn interest as a way to slow release rates or alter how tissues take up the drug. The basic structure lets innovation flourish, but anyone tinkering with modifications faces the challenge of staying within both legal and functional safety boundaries.
Picamilon Sodium appears under a few other names in the literature and on global shelves. It sometimes gets listed as N-Nicotinoyl-GABA sodium salt, Sodium nicotinoyl-GABA, or even just Picamilon. On some Russian and Eastern European pharmaceutical packs, the Cyrillic “Пикамилон” or Latinate “Pikamilon” identifies the pill or powder. Other listings use GABA-Nicotinate Sodium or Nicotinyl-GABA Sodium. These variations can cause headaches for researchers and buyers, since different names imply different purity grades or salt forms. Before purchasing or researching, confirming the exact synonym ensures a match with the intended use and legal standing.
Handling Picamilon Sodium calls for a steady set of personal and lab safety habits, even for experienced hands. Wearing gloves and safety glasses prevents the powder from brushing onto skin or getting into eyes, since mild irritation isn’t impossible. Spills call for immediate clean-up with water and disposable wipes, since dust can cause respiratory irritation if left unattended. Storage in tightly sealed containers, away from heat or light sources, preserves potency and cuts the risk of degradation. In countries where Picamilon is regulated as a prescription drug, packing, dispensing, and quality control land under government oversight, demanding logbooks and traceability from raw material to finished product. Labs and manufacturers train employees to keep data logs on pH, temperature, and humidity through each synthesis or packaging run. These operational standards help head off mistakes that could affect both human health and research reliability.
Picamilon mostly gets attention for supporting mental sharpness, mood regulation, and neuroprotection. Clinicians in some countries prescribe it for chronic anxiety, migraines, and issues tied to poor cerebral blood flow. Patients with mild cognitive challenges or mood swings sometimes turn to it—with or without a formal doctor’s note—hoping for better memory, clearer thought, or gentler stress responses. Researchers in neuroscience study its impact on GABA signaling, blood vessel dilation, and possible roles in slowing certain types of brain cell damage. The sports and fitness world occasionally points to its effect on focus or “mental endurance,” though claims here spin into the gray area where robust clinical data thin out. Some users also report better sleep or reduced irritability, but double-blind studies run short on strong numbers. Each application draws on Picamilon’s one-two punch: delivering GABA’s calming influence while using niacin’s vascular effects to pep up delivery to the brain.
Research digs deep into how Picamilon navigates human metabolism, how easily it moves from bloodstream to neurons, and how lasting its actions remain after dosing. Russian literature from the 1980s and 1990s supplies many of the early case studies and clinical trials, showing benefits in anxiety, cognitive decline, and vascular conditions. Western scholars take a more cautious stance, publishing trials that highlight both promise and gaps—asking for more head-to-head comparisons with other treatments, larger sample sizes, and multi-center replication. There’s ongoing curiosity about combining Picamilon with other nootropics or psychiatric meds, aiming to maximize benefits while keeping interactions and side effects in check. Animal models often fill in for large-scale human work, showing how modified structures might blunt toxicity or refine the compound’s reach. Research money still chases the prospect of a brain support tool that manages mood and focus without triggering jitters, dependency, or heart strain. The R&D path isn’t just about product claims, but also about understanding the gut, brain, and enzyme networks that govern how Picamilon decides where to work.
Safety data for Picamilon stretches over forty years, but human research leaves some open doors. Earlier animal studies flagged fairly high tolerance at standard dosages, with no dramatic organ or brain changes at therapeutic levels, though overdoses saw side effects like drop in blood pressure or agitation. Some Russian clinical trials claim a good safety profile for patients with anxiety or vascular issues, even in extended use, yet fail to capture rare events or subtle shifts in long-term users. A handful of published cases blame overuse or blending Picamilon with other drugs for headaches, digestive upset, or mood swings. Western regulatory agencies lean on gaps in independently confirmed toxicity studies to justify strict rules—and many doctors echo those concerns. For now, the agreed message is to keep doses within suggested guidelines, avoid stacking with untested combo therapies, and stop use if side effects start up. More follow-up studies and real-world monitoring could clarify who stands to benefit and how to identify those who might run into trouble.
Picamilon Sodium’s future follows the road that ties regulatory scrutiny to new science. Demand for cognitive enhancers won’t let up, especially as society ages and younger folks look for ways to stay competitive. Drug formulators keep tinkering with new salt forms, delivery vehicles, and combo pills to lengthen effect or fine-tune absorption. Some biotech startups eye Picamilon-inspired structures for neuroprotection in stroke, dementia, or traumatic brain injury. Newer clinical trial models built around genetic testing and real-time data could enable more precise mapping of who responds best to Picamilon. Funding for large, multi-center studies may settle questions about safety, ideal dosing, and side effects, possibly paving the way for broader medical acceptance outside Eastern Europe. The push for transparency and real-world evidence will help weed out exaggerated claims and make sure only the best-supported uses pass regulatory review. The coming decade looks set to shape where Picamilon fits among the dozens of brain-boosting molecules now on the scene.
Picamilon Sodium sounds like something out of a chemistry lab, and in a way, that’s spot on. This compound came from Russian labs back in the 1960s, designed as a sort of hybrid between GABA (a neurotransmitter) and niacin (vitamin B3). Scientists aimed to create a substance that could cross the blood-brain barrier and, once inside, offer potential cognitive or calming effects that pure GABA can’t deliver on its own.
When someone swallows a Picamilon tablet, the body breaks it down into GABA and niacin. By linking these two, researchers discovered they could sneak GABA into the brain because niacin acts as a delivery driver, carrying it across the usually restrictive blood-brain barrier. GABA, left to its own, mostly stays out of the brain when taken as a regular supplement—the gut just doesn’t let it through. The theory is that more GABA in the brain might help with relaxation, mood, and even clarity of thought.
In Russia, doctors have used Picamilon Sodium for decades under prescription for things like anxiety, depression, migraines, and even stroke recovery. In the US and many other places, it hasn’t earned the FDA’s approval as a drug. Manufacturers in supplement circles touted Picamilon for its focus and calming claims, but some consumer products landed in trouble because advertising got ahead of the actual research.
People searching for natural ways to combat stress or sharpen their attention have stumbled on Picamilon in various supplements. Reviews online spill over with stories—some claiming improved sleep, others swearing it calms a buzzing brain before a big test. Personal experience lines up with this: folks feel noticeably more relaxed taking it, but it’s not always clear if this comes from placebo or genuine brain chemistry shifts.
What makes Picamilon different from vitamins or regular GABA supplements circles back to that blood-brain barrier trick. Early Russian studies showed some improvement for patients struggling with anxiety or headaches. A handful of animal studies and some small-scale clinical work in humans back up its ability to lift mood or improve blood flow in the brain. Still, peer-reviewed research from outside Russia remains limited.
Major concerns haven’t vanished. American regulators raised eyebrows because no one ran robust, US-based safety trials. This gap left a lot of questions unanswered: How much is too much? Does it build up in the body and lead to side effects? Reports from supplement users occasionally mention headaches, irritability, and even light sensitivity—not exactly the mix you want from something meant to destress you. Retailers pulled it from shelves by 2015 at the FDA’s urging.
The Picamilon phenomenon spotlights the gap between supplement hype and rigorous science. People want quick fixes for mental pressure and brain fog. Picamilon promised both, at least on paper. History keeps playing out like this: new compounds pop up, draw excitement, then wind up in regulatory limbo after safety questions surface. With Picamilon, the answer to problems like anxiety and focus isn’t a mystery powder to slip under the radar. Solutions can start with lifestyle—exercise, steady sleep, honest conversations with a healthcare professional. “Magic bullets” almost always come with a price.
New research continues to surface about compounds like Picamilon. Only getting there through large, open human trials will close the knowledge gaps. Until that happens, skepticism and caution go a long way—for individuals and for the supplement industry as a whole. Instead of reaching for the next new tablet or powder, most folks benefit from proven habits and support before rolling the dice on untested brain chemistry tweaks.
Picamilon sodium pulls together two familiar substances: niacin (also called vitamin B3) and GABA, a neurotransmitter people associate with calm. Russian scientists once explored the idea of linking these molecules to help GABA cross the blood-brain barrier. Out in the wild, GABA supplements can’t make much difference because the brain blocks most of it, the same way a nightclub bouncer keeps out the rowdy crowd. Joined with niacin, though, it can slip through and start to do its work.
Lots of folks go after Picamilon sodium for more focus or a cooler head in stressful times. Not all stresses fade away with meditation or exercise, especially for folks with jittery minds. There’s something about real world worries—like waiting on test results from a doctor or slogging through a work deadline—that drains your energy. I’ve seen people reach for Picamilon sodium during a relentless period of office projects and after too many sleepless nights. They say it takes the edge off, without that spacey feeling some calming supplements bring.
Doctors and researchers in Russia used to prescribe it for migraines, anxiety, and even high blood pressure. Some of the studies done decades ago claim Picamilon sodium cuts into symptoms of anxiety and improves mental stamina. These results line up with that sense of ease you can get from GABA, mixed with the brain-friendly boost from niacin.
People hunting for a clear head and easy nerves scan labels for nootropics that don’t crash their mood or make them fidgety. Caffeine keeps you up but it can lead to jitters and uneven energy. Picamilon sodium doesn’t spark you up but smooths you out gently. Those who used it in their daily routine found it easier to keep on track with work. My own attempts with herbal teas and meditation never shook that wired feeling; Picamilon sodium brought calm without knocking out my focus.
Travelers fighting jet lag, students during finals, or folks in busy offices—you run into all kinds hoping for sharper thinking with less stress. That’s where Picamilon sodium draws attention. There aren’t many supplements out there designed to cross into the brain and tackle agitation right at the source.
The FDA in the United States doesn’t permit Picamilon sodium as a dietary supplement. That doesn’t mean the whole story ends there. Instead, it signals that regulation trails behind research and market interest, especially for newer compounds outside the usual herbal remedies. Looking at Russian science from the past, it’s easy to see why some people embrace this supplement. The rush of new nootropics also means more honest research—especially in English and with clear data—could help us understand if people everywhere get the same results.
Anyone chasing that extra bit of focus or less anxiety can do well to follow a cautious path. Talking with a doctor is smart, since Picamilon sodium can interact with medication or health conditions. The interest in these kinds of brain-boosters isn’t going away. What matters most is making choices with the right information, tuning into what works for your own mind, and keeping an eye out for new studies that shed fresh light on the risks and rewards.
Picamilon Sodium comes from a combination of niacin and GABA, first developed in Russia for cognitive and mood support. Despite its popularity in supplement circles, most Western doctors haven’t used it in daily practice, so recommendations sometimes look patchy. In my own search for reliable numbers, actual published studies from Russian sources often used daily doses between 50 mg and 200 mg, broken into two or three doses. This approach tries to match the way the body processes the compound throughout the day, instead of dumping it in all at once. Reports suggest a typical adult starts low—around 50 mg in the morning—then slowly works up, gauging how the body and mind react. Russian clinical experience showed 60–200 mg daily as practical, rarely going above 300 mg unless under direct medical attention.
People often self-prescribe Picamilon Sodium after reading positive testimonials online. I’ve watched friends try it because they want a sharper mind or less anxiety, counting on this supplement because pharmaceuticals either disappointed or gave them side effects. But trusting online advice without medical input can backfire. Side effects of going too high can include flushed skin (thanks to the niacin), blood pressure drops, or headaches. Some people get stomach irritation. There’s a void in large-scale, placebo-controlled trials outside Russia, so it’s wise not to get carried away by exaggerated claims. A healthcare provider should be in the loop before someone with a heart condition or low blood pressure ever touches this stuff.
Every person seems to process Picamilon Sodium differently. Some people metabolize niacin quickly, others feel warm and jittery from the same amount. What works for an anxious 28-year-old doesn’t always translate to someone in their sixties looking to stave off memory lapses. Plus, health conditions like liver or kidney issues change how drugs move in the body. Older studies give us clues, but the lack of robust new data outside Russia adds an uncertainty that makes me far more cautious about blanket advice. I rely on talking with doctors who understand supplements and nootropics for support and don’t make sudden jumps in dosage without their backing.
Product labels for Picamilon Sodium often read “not evaluated by the FDA.” This adds a layer of risk for the buyer. I always check where the company sources its ingredients and whether they share lab test results. Since regulatory oversight in supplements remains spotty, the burden of safety shifts more onto the user. I’ve learned that even vitamins can hurt in the wrong hands or amounts. Sharing information about actual research and known risks empowers smarter choices, rather than chasing miracle supplements by word of mouth.
Before jumping to Picamilon Sodium or any supplement aiming to boost brain power, lifestyle choices play a larger role than we give them credit for. Basic groundwork—consistent sleep, movement, and connecting with others—does more for brain health than most realize. For those struggling with focus or anxiety, talking with a professional before taking supplements like Picamilon Sodium cuts down on surprises or long-term harm. New research and transparency from companies could help fill gaps in guidance, but until then, steady and well-informed steps offer the best results for body and mind.
Picamilon Sodium almost always gets mentioned in conversations about brain health and mental focus. Many folks looking for calmness without grogginess latch onto it. It’s not just the science crowd. College students, shift workers, and people fighting worry all talk about its promise. This compound comes from combining niacin and GABA, hoping to pass easily into the brain and boost those calming GABA signals. Russia’s pharmacies once handed out this supplement for stress and mood, but most European and North American health agencies keep it off shelves as a dietary aid.
Stories pile up online, so it helps to sort firsthand experience from rumor. Mild headaches top the list among users. Some folks describe feeling lightheaded or foggy, especially after pushing dosage too high. Stomach upset and redness in the face show up less often, but still enough that people take notice. Sleep can stumble, with some reports of restlessness if doses come late in the day.
More pressing concerns surfaced in Russia, at least before Picamilon got the boot there. A handful of clinical reports tied this compound to rapid mood changes, rainclouds of sadness, or agitation. Blood pressure swings popped up in a few medical write-ups, which matters most for folks already dealing with hypertension or similar troubles.
People with kidney or liver conditions stand at a higher risk. Since Picamilon breaks down in those organs, existing problems might turn mild side effects into bigger trouble. Pregnant or nursing mothers, kids, and those on psychiatric medication should keep a safe distance. Not much data covers these groups, and risking the unknown rarely pays off.
Mixing Picamilon with alcohol or sedatives can exaggerate its effect. Some international drug regulators flagged this after seeing interactions lead to confusion, stumbling, or even a sudden drop in alertness. Safety studies haven’t convinced American or European watchdogs that this compound belongs on shelves, which says a lot about caution over claims.
A lot of the side effect stories link back to one core problem—nobody can be totally sure what’s inside that generic bottle. Since the FDA doesn’t regulate Picamilon as a supplement in the U.S., buyers rely on online sellers with unknown quality standards. Fake products or incorrect dosages look the same as the real deal at first glance. Contamination or mislabeling remain big risks. It’s not just a fear tactic—tests from the Oregon Department of Justice found mislabeled “Picamilon” in local supplement shops.
Researching any new supplement makes sense. Look up where a product comes from before swallowing a single capsule. If possible, ask for proof of third-party testing. Health professionals with real-world experience can spot red flags that casual buyers miss. Folks with any prior heart, mood, or liver conditions should start with a doctor’s opinion, not a blog or forum post.
Better laws around supplement labeling and ingredient verification could help tamp down shady claims and keep dangerous fakes away from store shelves. Open reporting systems for side effects and better consumer education about foreign drugs would also make a difference for people who feel the pull toward cognitive enhancers.
From my own experience watching health trends and working with stress-related problems, people often grab at anything promising mental clarity or peace. Every promising shortcut always brings hidden costs. If someone feels tempted by Picamilon or similar pills, their most honest ally remains good science, careful self-tracking, and a direct conversation with someone who knows their full health story.
Picamilon Sodium combines niacin and GABA, two compounds that, on their own, are familiar to anyone interested in supplements or basic nutrition. In the old Soviet Union, hospitals prescribed it for anxiety, depression, and even circulatory issues. The idea: boost blood flow to the brain and give people more focus and calm at the same time. Some amateur athletes and folks with restless minds discovered it, started swearing by it, and gave it a little buzz outside Russia.
People often ask about the legal gray zones around newer supplements. Picamilon’s story shows how quickly the landscape can change. Back in 2015, the U.S. Food and Drug Administration took a clear stance. After reviewing data and looking at how picamilon gets made, the agency said it doesn’t fit the definition of a dietary ingredient under the law. The FDA has since sent warning letters to companies selling products with picamilon inside, telling them to take it off the market. The state of Oregon also stepped in during 2016, banning retail sales across health stores and online shops that operate in the state.
Some online outlets outside the United States will still ship picamilon. These sites usually operate in places with looser rules around supplements—Ukraine, China, Russia. While a few U.S. sellers may quietly move stock under-the-table or rebrand picamilon as something else, the risk now sits with the buyer. The law views picamilon as an unapproved drug, not a simple off-the-shelf product.
Interest in picamilon usually comes from people chasing sharper focus and looking for relief from anxiety. The compound holds a certain appeal for those who have tried the mainstream options without much luck or who experience side effects from standard prescriptions. The body of serious research on humans remains thin. Early Soviet studies showed positive effects, but those studies rarely held up under scrutiny from modern labs. Many anecdotes get shared online, fueling more curiosity, even as official research lags.
Some people also think supplement access should fall on the buyer’s shoulders, not big government. But federal and state actions show that regulators want to draw limits, especially when a compound claims to cross the blood-brain barrier and change brain chemistry.
Plenty of people want help finding peace of mind without putting themselves in a legal bind. If you want to feel more relaxed, it makes sense to look for options supported by more established evidence. Magnesium, L-theanine, and simple aerobic exercise all have research backing and sit well within legal guardrails. Cognitive Behavioral Therapy has also shown consistent results for anxiety, no prescription needed.
If picamilon catches your interest because regular life feels overwhelming or sleep won’t come easy, talk to a health provider. Even though web forums and social media buzz around new compounds, your doctor or a trustworthy pharmacist keep up with both safety records and changing law. Taking a shortcut with an unapproved nootropic sometimes brings more trouble than relief.
For now, the only legal way to get picamilon in the U.S. runs through a clinical trial or a research lab—never your local supplement aisle. Shoppers would do better choosing well-studied, regulated options and focusing on transparency about what goes into every product. Staying curious always matters, but so does sticking to choices that won’t put your good name or health on the line.
| Names | |
| Preferred IUPAC name | sodium 4-(pyridine-3-carbonylamino)butanoate |
| Other names |
Pikamilon Sodium Nicotinoyl-GABA sodium N-nicotinoyl-gamma-aminobutyric acid sodium salt Sodium nicotinoyl-GABA |
| Pronunciation | /paɪˈkæmɪˌlɒn ˈsoʊdiəm/ |
| Identifiers | |
| CAS Number | 62936-56-5 |
| Beilstein Reference | 3561776 |
| ChEBI | CHEBI:79016 |
| ChEMBL | CHEMBL2106021 |
| ChemSpider | 86406176 |
| DrugBank | DB09217 |
| ECHA InfoCard | 03c8f6db-0b5c-4a50-b2fe-cfc00208087a |
| EC Number | 2758-92-9 |
| Gmelin Reference | 2031229 |
| KEGG | C14767 |
| MeSH | D03ZZA2S9X |
| PubChem CID | 166549283 |
| RTECS number | UW992K5FVR |
| UNII | I4JZ2XJZ5O |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C10H11N2NaO3 |
| Molar mass | 206.109 g/mol |
| Appearance | White or almost white crystalline powder |
| Odor | Odorless |
| Density | 1.21 g/cm3 |
| Solubility in water | Soluble in water |
| log P | -1.39 |
| Acidity (pKa) | 10.85 |
| Basicity (pKb) | 11.2 |
| Refractive index (nD) | 1.582 |
| Dipole moment | 2.11 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 276.1 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | N06BX22 |
| Hazards | |
| Main hazards | May cause eye, skin, and respiratory tract irritation. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | ❗🤰🚫🍺💊 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | Wash hands thoroughly after handling. Do not eat, drink or smoke when using this product. IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. Rinse mouth. |
| LD50 (median dose) | LD50 (median dose) of Picamilon Sodium: "5000 mg/kg (oral, rat) |
| NIOSH | RA2455000 |
| PEL (Permissible) | 3 mg/m³ |
| REL (Recommended) | 50-200 mg per day |
| IDLH (Immediate danger) | Not Established |
| Related compounds | |
| Related compounds |
Picamilon Niacin Gamma-Aminobutyric Acid (GABA) Phenibut |
